)
)
Bayer Investor Relations Material
Latest events
Q3 2024
Bayer
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Bayer AG
Access all reports
Segment Data
Access more data
Net sales by
Business area
Crop Science
Pharmaceuticals
Consumer Health
Enabling Functions and Consolidation
Other
Expenses by
Financials
Bayer AG operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The company researches, develops, manufactures, and markets prescription products primarily for the areas of cardiology and women's healthcare; and specialty therapeutics in the areas of oncology, hematology, and ophthalmology. It is also involved in developing over-the-counter medications and dietary supplements.
Key slides for Bayer AG
Latest articles
)
Evolution: The Live Casino Juggernaut
With ~49% CAGR since its 2015 IPO, 60%+ EBIT margin, and global dominance in live casino, the story of Evolution is truly one for the books.
22 Nov 2024
)
House of Warhammer: The Inner Workings of Games Workshop
A look under the hood of Games Workshop, a high-margin business in an incredibly niche market, with sky-high stock returns.
15 Nov 2024
)
Crafting a Solid Equity Story: A Strategic Guide for Investor Relations Professionals
Craft a compelling equity story: Align narratives with data to attract ideal investors and build trust with Quartr Pro's powerful IR tools.
13 Nov 2024
Ticker symbol
BAYN
Country
🇩🇪 Germany